Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ABIRATERONA STRAGEN 250 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ABIRATERONA STRAGEN 250 MG COMPRIMIDOS EFG

Approved

STANDARD

ABIRATERONA STRAGEN 250 MG COMPRIMIDOS EFG

Stragen France🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 14, 2021
Approval ID: 729d3ad849851fa2
Company: Stragen France
Type: Standard

Approval Details

Approval Id: 729d3ad849851fa2
Drug Cima Aemps Name: ABIRATERONA STRAGEN 250 MG COMPRIMIDOS EFG
Register Number: 85916
Holder Company Name: Stragen France
Marketing Company Name: Stragen France
Holder Company Detail Path: /organization/stragen-france
Marketing Company Detail Path: /organization/stragen-france
Authorization Date: 2021-04-14
Dosage Form: COMPRIMIDO
Dose: 250 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Stragen France
Company Detail Path: /organization/stragen-france

Company Information

Pharmaceutical Company Name: STRAGEN-FRANCE
Country Name: France
City Name: lyon,auvergne rhone alpes,country_fr
Address: 30 RUE EDOUARD NIEUPORT

Active Ingredients

ABIRATERONA ACETATO

250 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 14, 2021

Approval ID

729d3ad849851fa2

Type

Standard

Back to CIMA-AEMPS Approvals